Lung Cancer Overview
Innovation in Diagnostics & Treatment
As the first hospital in the region to obtain a PET-CT scanner, which can detect lung cancer in its earliest stages, UVA Cancer Center's Lung Cancer Team strives to stay at the forefront of diagnostics and treatment for cancers of the chest. Our doctors recently pioneered a new technique to find tiny lesions in the lung earlier than ever before, making UVA a strong choice for lung screenings and cancer treatment.
Minimally-Invasive, Targeted Procedures
We offer the latest technology for procedures such as lung-sparing and minimally-invasive, video-assisted surgery, high-dose rate (HDR) brachytherapy, stereotactic radiosurgery and , which deliver high doses of carefully-targeted radiation reducing room for error and patient keeping positioning the same. We also perform minimally invasive video-assisted thoracic surgery to remove lung cancers whenever possible.
Multidisciplinary Team Improves Patient Outcomes
Our multidisciplinary team of surgical and radiation oncologists, medical oncologists, pathologists, thoracic nurses and more, who are researchers and experts in their respective fields, offers a unique level of care and treatment options that patients don't have access to at other cancer centers in this region. By integrating research and clinical services, we're quickly translating our discoveries into effective treatments for patients. The team meets weekly to discuss each specific case to be sure the most effective treatment plan is in place for every patient. Our extensive experience with all forms of lung cancer (more than 100 lung resections annually) translates into better outcomes and easier recoveries for our patients.
The lung cancer team at UVA Cancer Center pioneered a specialized technique called to help locate and remove small or indeterminate lung nodules that may appear in results from imaging procedures. A major advantage to this procedure is that the whole nodule is removed rather than obtaining only a small sample of tissue. If it is cancerous or has the potential to become malignant, this is a life-saving procedure. We have successfully performed this technique on 250 patients with small, indeterminate lung nodules.
Featured Article: Novel Collaboration Leads to New Treatment Options
Sometimes the Most Promising Ideas Come from Unexpected Places
At UVA, John Bushweller, PhD, and his team have identified a unique class of inhibitors that may block abnormal cell growth in acute myeloid leukemia. What’s more, Bushweller and his team quickly realized their discovery could be a paradigm for treating other forms of cancer, including ovarian, colon, and lung. Read the full article Investing in Hope, back cover.